The future of precision medicine and transforming genomic research lies in the critical role of AI. The growing gap between massive genomic data collection and its clinical interpretation are now essential for complex analysis at scale.

On Industry Insight, Lynlee Foo speaks to Dr Ilya Burkov, Global Head of Healthcare & Life Sciences Growth, Nebius to find out how Singapore’s strong AI ecosystem can position the country as a global leader in genomic medicine and biomedical research.